Verification of speech spectrum audibility for pediatric Baha Softband users with craniofacial anomalies

Insights

The Baha Softband significantly improves hearing for children with bilateral conductive hearing loss. This bone conduction device makes speech frequencies audible, aiding audibility for young patients.

Area of Science:

  • Audiology
  • Pediatric Otolaryngology
  • Biomedical Engineering

Background:

  • Bilateral conductive hearing loss in children can impede speech development.
  • Early intervention is crucial for managing hearing loss in pediatric populations.
  • Bone conduction devices offer a non-surgical option for hearing rehabilitation.

Purpose of the Study:

  • To evaluate the effectiveness of the Baha Softband in improving audibility for children with bilateral conductive hearing loss.
  • To verify audibility across the speech spectrum (500-4000 Hz) with Baha Softband amplification.
  • To provide data supporting the use of Baha Softband for pediatric hearing loss.

Main Methods:

  • Retrospective chart review of 25 children (6 months to 18 years) with craniofacial disorders and conductive hearing loss.
  • Pretest-posttest repeated measures design assessing aided and unaided soundfield audiometric thresholds.
  • Functional gain calculation and comparison of aided thresholds to target speech spectrum levels.

Main Results:

  • Significant improvement in soundfield thresholds observed with Baha Softband amplification across tested octave frequencies.
  • Aided thresholds met target levels for speech spectrum audibility in a high percentage of cases, exceeding the 80% criterion.
  • The Baha Softband demonstrated clear benefits in audibility for the pediatric participants.

Conclusions:

  • The Baha Softband is beneficial for providing audibility of the speech spectrum in infants and children with bilateral congenital conductive hearing loss.
  • These findings support the use of the Baha Softband as an effective intervention for pediatric hearing loss.
  • The study provides valuable data for third-party reimbursement and clinical decision-making.
Abstract

Related Concept Videos